News
BALLERUP, Denmark I June 03, 2025 I LEO Pharma A/S, a global leader in medical dermatology, today announced the initiation of the phase 2a proof-of-concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback